Migration of retinal pigment epithelial cells is EGFR/PI3K/AKT dependent

Frontiers in Bioscience - Scholar

Volumn 5 S, Issue 2, 2013, Pages 661-671

  Zhang, Lei ^a   Wang, Fenghua ^b   Jiang, Yuan ^a,b   Xu, Shan ^a,b   Lu, Fengqing ^a,b   Wang, Wenqiu ^a,b   Sun, Xiangjun ^a   Sun, Xiaodong ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Eye Research Institute   (China)

Author keywords

AKT; ARPE 19 cell; EGF; EGFR; Migration; PI3K

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; QUINAZOLINE DERIVATIVE; RETINAL; TYRPHOSTIN;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; PIGMENT CELL; PROTEIN PHOSPHORYLATION; RETINA CELL; SIGNAL TRANSDUCTION; WOUND HEALING; CELL GROWTH; CELL LINE; CELL MOTION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PIGMENT EPITHELIUM;

CELL GROWTH PROCESSES; CELL LINE; CELL MOVEMENT; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETINAL PIGMENT EPITHELIUM; RETINALDEHYDE; SIGNAL TRANSDUCTION; TYRPHOSTINS;

EID: 84883665768     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s398     Document Type: Article

References (34)

1. Charteris, D.G., C.S. Sethi, G.P. Lewis & S.K. Fisher: Proliferative vitreoretinopathy-developments in adjunctie treatment and retinal pathology. Eye 16, 369-374 (2002)
2. Machemer, R. & H. Laqua: Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation) Am J Ophthalmol 80,1-23 (1975)
3. Fisher, S.K., G.P. Lewis, K.A. Linberg & M.R. Verardo: Cellular remodeling in mammalian retina: results from studies of experimental retinal detachment. Prog Retin Eye Res 24,395-431 (2005)
4. Roldán-Pallarés, M., R. Rollín, A. Mediero, J.C. Martínez-Montero, A. Fernández-Cruz, V. Bravo-LIata & R. Fernández-Durango: Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy. Mol Vis 11,461-471 (2005)
5. Canataroglu, H., I. Varinli, A.A. Ozcan, A. Canataroqlu, F. Doran & S. Varinli. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy: Ocul Immunol Inflamm 13,375-381 (2005)
6. Baudouin, C., D. Fredj-Reygrobellet, F. Brignole, F. Nègre, P. Lapalus & P. Gastaud: Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy. Ophthalmic Res 25, 52-59 (1993)
7. Banerjee, S., V. Savant, R.A. Scott, S.J. Curnow, G.R. Wallace & P.I. Murray: Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders. Invest Ophthalmol Vis Sci 48,2203-2207 (2007)
8. Jin, M., S. He, V. Worpel, S.J. Ryan & D.R. Hinton: Promotion of adhesion and migration of RPE cells to provisional extracellular matrices by TNF-alpha. Invest Ophthalmol Vis Sci 41, 4324-4332 (2000)
9. Hubbard, S.R. & W.T. Miller: Receptor Tyrosine Kinases: Mechanisms of Activation and Signaling. Curr Opin Cell Biol 19,117-123 (2007)
10. Schneider, M.R. & E. Wolf: The epidermal growth factor receptor ligands at a glance. J Cell Physiol 218,460-466 (2009)
11. Jin, S., Y. Wang & G. Jiang: Measurements of serum and subretinal fluid before and after surgery of retinal detachment (in Chinese) Zhonghua Yan Ke Za Zhi 33,36-38 (1997)
12. Xu, K.P. & F.S. Yu: Cross Talk between c-Met and Epidermal Growth Factor Receptor during Retinal Pigment Epithelial Wound Healing. Invest Ophthalmol Vis Sci 48,2242-2248 (2007)
13. Hollborn, M., I. Iandiev, M. Seifert, U.E. Schnurrbusch, S. Wolf, P. Wiedemann, A. Bringmann & L. Kohen: Expression of HB-EGF by retinal pigment epithelial cells in vitreoretinal proliferative disease. Curr Eye Res 31,863-874 (2006)
14. Yan, F., Y.N. Hui, J.X. Ma, Q.H. Han & C.M. Guo: Expression of epidermal growth factor receptor in periretinal membranes of proliferative vitreoretinopathy. (in Chinese) Rec Adv Ophthalmol 23:8-10 (2003)
15. Yan, F., Y.N. Hui, Y.J. Li, C.M. Guo & H. Meng: Epidermal growth factor receptor in cultured human retinal pigment epithelial cells. Ophthalmologica 221,244-250 (2007)
16. Hecquet, C., G. Lefevre, M. Valtink, K. Engelmann & F. Mascarelli: Activation and role of MAP kinasedependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation. Invest Ophthalmol Vis Sci 43,3091-3098 (2002)
17. Chen, Z., C.Z. Chen, W.R. Gong, J.P. Li & Y.Q. Xing: Integrin-alpha5 mediates epidermal growth factor-induced retinal pigment epithelial cell proliferation and migration. Pathobiology 77, 88-95 (2010)
18. Lee, H., S.J. O'Meara, C. O'Brien & R. Kane: The role of gremlin, BMP antagonist, and epithelial-tomesenchymal transition in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 48, 4291-4299 (2007)
19. Jiang, Q., C.L. Zhou, Z.G. Bi & Y.S. Wan: EGFInduced Cell Migration Is Mediated by ERK and PI3K/AKT Pathways in Cultured Human Lens Epithelial Cells. J Ocul Pharmacol Ther 22, 93-102 (2006)
20. Price, J.T., T. Tiganis, A. Agarwal, D. Djakiew & E.W. Thompson: Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3'-kinase and phospholipase Cdependent mechanism. Cancer Res 59, 5475-5478 (1999)
21. Wang, J.N., W.Z. Wan, R.H. Sun, Y. Liu, X. Sun, D. Ma & N. Zhang: Reduction of Akt2 expression inhibits chemotaxis signal transduction in human breast cancer cells. Cellular Signaling 20, 1025-1034 (2008)
22. Ye, M., D.N. Hu, L. Tu, X. Zhou, F. Lu, B. Wen, W. Wu, Y. Lin, Z. Zhou & J. Qu: Involvement of PI3K/Akt Signaling Pathway in Hepatocyte Growth Factor-Induced Migration of Uveal Melanoma Cells. Invest Ophthalmol Vis Sci 49:497-504 (2008)
23. Dunn, K.C., A.E. Aotaki-Keen, F.R. Putkey & L.M. Hjelmeland: ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 62, 155-169 (1996)
24. Sun, R., P. Gao, L. Chen, D. Ma, J. Wang, J.J. Oppenheim & N. Zhang: Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. Cancer Res 65,1433-1441 (2005)
25. Sebastian, S., J. Settleman & S.J. Reshkin: The Complexity of targeting EGFR signaling in cancer: from expression to turnover. Biochim Biophys Acta 1766,120-139 (2006)
26. Rambhatla, L., C.P. Chiu, R.D. Glickman & C. Rowe-Rendleman: In vitro differentiation capacity of telomerase immortalized human RPE cells. Invest Ophthalmol Vis Sci 43,1622-1630 (2002)
27. Steindl-Kuscher, K., M.E. Boulton, P. Haas, A. Dossenbach-Glaninger, H. Feichtinger & S. Binder: Epidermal growth factor: The driving force in initiation of RPE cell proliferation. Graefes Arch Clin Exp Ophthalmol 249,1195-1200 (2011)
28. Chen, H.C., Y.T. Zhu, S.Y. Chen & S.C. Tseng: Wnt signaling induces epithelial-mesenchymal transition with proliferation in ARPE-19 cells upon loss of contact inhibition. Lab Invest 92,676-687 (2012)
29. Chang, C.P., C.S. Lazar, B.J. Walsh, M. Komuro, J.F. Collawn, L.A. Kuhn, J.A. Tainer, I.S. Trowbridge, M.G. Farguhar & M.G. Rosenfeld: Ligand-induced internalization of the epidermal growth factor receptor is mediated by multiple endocytic codes analogous to the tyrosine motif found in constitutively internalized receptors. J Biol Chem 268, 19312-19320 (1993)
30. Waterman, H., I. Sabanai, B. Geiger & Y. Yarden: Alternative intracellular routing of ErbB receptors may determine signaling potency. J Biol Chem 273, 13819-13827 (1998)
31. Vanhaesebroeck, B., P.K. Vogt & C. Rommel: PI3K: from the bench to the clinic and back. Curr Top Microbiol Immunol 347, 1-19 (2010)
32. Franke, T.F.: Intracellular signaling by Akt: bound to be specific. Sci Signal 1: pe 29 (2008)
33. Zhou, G.L., D.F. Tucker, S.S. Bae, K. Bhatheja, M.J. Birnbaum & J. Field: Opposing roles for Akt1 and Akt2 in Rac/Pak signaling and cell migration. J Biol Chem 281, 36443-36453 (2006)
34. Morgensztern, D. & H.L. McLeod: PI3K/Akt/mTOR pathway as a target for cancer therapy. Anticancer Drugs 16,797-803 (2005)